FindTrial
Sign In

Role of biomarkers to predict pregnancy outcome in gestational diabetes

Prediction of materno-fetal outcome in gestational diabetes mellitus using SFLT1/PLGF Ratio in third trimester. - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064784
Enrollment
200
Registered
2024-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O992- Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

Interventions

Intervention1: Nil: Nil

Sponsors

Vardhman Mahavir Medical College AND SAFDARJUNG HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Antenatal women with singleton pregnancy and GDM in third trimester

Exclusion criteria

Exclusion criteria: 1 Pre-pregnancy diabetes (type 1 and type 2). 2 Congenital malformation in fetus. 3 Antenatal women with intra-uterine fetal death (IUFD). 4 Pre-existing medical comorbidity –chronic hypertension, Overt DM, Chronic Kidney Disease,Heart disease etc.

Design outcomes

Primary

MeasureTime frame
SFLT 1 and PLGF ratio. Timepoint: Baseline—

Secondary

MeasureTime frame
Materno-fetal outcome in women with gestational diabetes mellitus. Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Prity Yogi

VMMC and Safdarjung hospital, Delhi

prityyogi@gmail.com919717364342

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026